Autolus (NASDAQ: AUTL) director awarded 47,500 options and 31,667 RSUs
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Autolus Therapeutics plc director Cynthia M. Butitta received new equity awards. She was granted options to buy 47,500 shares of American Depositary Shares at an exercise price of $1.61 per share, expiring on June 29, 2036, vesting in twelve equal monthly installments starting July 29, 2026.
She also received 31,667 restricted share units, each representing one American Depositary Share, vesting in a single installment on June 29, 2027. These awards are compensation-related grants rather than open‑market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
BUTITTA CYNTHIA M
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Restricted Share Units | 31,667 | $0.00 | -- |
| Grant/Award | Share Option (Right to Buy) | 47,500 | $0.00 | -- |
Holdings After Transaction:
Restricted Share Units — 31,667 shares (Direct, null);
Share Option (Right to Buy) — 47,500 shares (Direct, null)
Footnotes (1)
- Each restricted stock unit (RSU) represents a contingent right to receive one share of the Issuer's American Depositary Shares. Each American Depositary Share is convertible at any time at the option of the Reporting Person into one Ordinary Share. The RSUs vest in one installment on June 29, 2027. Share options vest in twelve equal monthly installments commencing on July 29, 2026.
Key Figures
Stock options granted: 47,500 shares
Option exercise price: $1.61/share
Option expiration: June 29, 2036
+3 more
6 metrics
Stock options granted
47,500 shares
Share Option (Right to Buy) grant on June 29, 2026
Option exercise price
$1.61/share
Exercise price for 47,500 options
Option expiration
June 29, 2036
Expiration date of granted options
RSUs granted
31,667 units
Restricted Share Units grant on June 29, 2026
RSU vesting date
June 29, 2027
Single-installment vesting for RSUs
Option vesting start
July 29, 2026
Monthly vesting begins, 12 equal installments
Key Terms
Restricted Share Units, Share Option (Right to Buy), American Depositary Shares, restricted stock unit (RSU), +1 more
5 terms
restricted stock unit (RSU) financial
"Each restricted stock unit (RSU) represents a contingent right to receive one share"
A restricted stock unit (RSU) is a promise from a company to give an employee company shares (or cash equal to their value) at a future date if certain conditions are met, such as staying with the company or hitting performance targets. For investors, RSUs matter because when they convert into actual shares they increase the number of shares available and can create selling pressure as employees cash out—think of them as a future paycheck paid in company stock.
exercise price financial
"conversion_or_exercise_price: "1.6100""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
What did Autolus Therapeutics (AUTL) director Cynthia Butitta receive in this Form 4?
Cynthia M. Butitta received equity compensation consisting of stock options and restricted share units. She was granted options on 47,500 American Depositary Shares and 31,667 restricted share units, both tied to Autolus Therapeutics plc, with specific vesting schedules over future dates.
How many Autolus Therapeutics (AUTL) options were granted to Cynthia Butitta?
She was granted options on 47,500 American Depositary Shares. These options carry a fixed exercise price of $1.61 per share and expire on June 29, 2036, with vesting occurring in twelve equal monthly installments beginning July 29, 2026.
What are the details of the RSU grant to the Autolus (AUTL) director?
Cynthia Butitta received 31,667 restricted share units, each representing one American Depositary Share of Autolus Therapeutics. According to the filing, these RSUs vest in a single installment on June 29, 2027, making them a time-based equity compensation award.
Are these Autolus (AUTL) transactions open-market buys or sells?
No, the transactions are equity awards, not market trades. The Form 4 classifies them under code A as grants or awards, meaning they are compensation-related acquisitions rather than open-market purchases or sales of Autolus Therapeutics shares.
What does the $1.61 exercise price mean for Autolus (AUTL) option grants?
The $1.61 exercise price is the fixed amount Cynthia Butitta must pay per share to exercise her options. She can acquire American Depositary Shares at this price before the options’ expiration on June 29, 2036, subject to the vesting schedule.